We have previously shown that both ethanol and fatty acids, when infused in healthy elderly individuals, caused acute insulin resistance. The mechanisms through which these effects were produced remained, however, uncertain. We now propose to investigate the hypothesis that ethanol and fatty acids produce insulin resistance by the same mechanism. Specifically, that 1) the major metabolic defect produced by ethanol and by fatty acids is inhibition of insulin stimulated glucose transport across cell membranes; 2) that ethanol and fatty acids produce this defect via intracellular accumulation of acetyl-CoA and 3) that in addition to acetyl-CoA, stimulation by insulin of the hexosamine pathway resulting in production of glucosamine, is needed for the full development of the ethanol and fatty acid mediated defect in the glucose transport system. Direct effects of ethanol and fatty acids on glucose transport will be examined in vivo using a dual tracer technique (3-0-methyl-D-glucose and D-mannitol) in combination with the forearm balance method and euglycemic-hyperinsulinemic clamping and in vitro in rat adipocytes, by determining glucose transporter (Glut4 and Glut1) mass and translocation from a cytosolic to a surface membrane pool. The role of acetyl-CoA as mediator of ethanol and fatty acid induced insulin resistance will be examined in vivo by determining acetyl-CoA conc in muscle biopsies obtained during euglycemic-hyperinsulinemic clamping and in vitro in rat adipocytes. The role of the hexosamine pathway in the desensitization of the insulin sensitive glucose transport system will be examined in rat adipocytes by blocking the rate limiting enzyme of this pathway (glutamine: fructose-6-phosphate-amidotransferase or GFAT) with and without addition of glucosamine (the product of the GFAT reaction). We hope that these studies will provide important information on ethanol and fatty acid mediated insulin resistance, an abnormality which appears to play a pivotal role in the pathogenesis of hypertension, type II diabetes, lipid disorders, and atherosclerotic vascular disease in elderly individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG007988-08
Application #
2457526
Study Section
Special Emphasis Panel (ZRG4-GRM (01))
Project Start
1990-01-01
Project End
2000-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
8
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Temple University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Boden, G (2003) Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 111:121-4
Boden, Guenther; Cheung, Peter; Stein, T Peter et al. (2002) FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283:E12-9
Boden, Guenther (2002) Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 5:545-9
Boden, G; Shulman, G I (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 Suppl 3:14-23
Itani, Samar I; Ruderman, Neil B; Schmieder, Frank et al. (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-11
Boden, G (2001) Pathogenesis of type 2 diabetes. Insulin resistance. Endocrinol Metab Clin North Am 30:801-15, v
Boden, G; Lebed, B; Schatz, M et al. (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612-7
Boden, G; Chen, X; Capulong, E et al. (2001) Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 50:810-6
Homko, C; Sivan, E; Chen, X et al. (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568-73
Boden, G; Chen, X; Stein, T P (2001) Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280:E23-30

Showing the most recent 10 out of 56 publications